Amortization of R and E Expenditures under the TCJA: Unintended Consequences and Policy Lessons for Innovation Incentives

This article examines the mandatory capitalization and amortization of research and experimental (R&E) expenditures under amended Internal Revenue Code §174, as a retrospective case study in unintended tax policy consequences. Before the Tax Cuts and Jobs Act (TCJA) of 2017, firms could immediately deduct R&E expenditures in the year incurred, preserving liquidity and maximizing the present value of associated tax shields. The TCJA eliminated this option, requiring domestic R&E costs to be amortized over five years and foreign R&E costs over fifteen, generating immediate and material distortions for innovation-intensive firms. Drawing on statutory analysis, corporate finance theory, firm-level case studies, and industry advocacy evidence, this article makes three principal contributions. First, it reframes the amortization mandate as an intertemporal tax policy intervention, quantifying how deduction deferral reduces the present value of tax shields and raises effective hurdle rates, particularly under risk-adjusted discount rates reflective of innovation uncertainty. Second, it extends R&E incentive research by analyzing the consequences of withdrawing a longstanding preference rather than introducing new benefits. Third, it situates the episode within broader debates on tax stability, liquidity constraints, and cross-provision interactions, especially with qualified small business stock under §1202 and deferred tax accounting under ASC 740, and offers evidence-based lessons for innovation-oriented tax design. The 2025 reversal through the One Big Beautiful Bill Act, while substantially corrective, left legacy harms that illustrate the durable costs of budget-driven policy misalignment with the distinctive economics of R&E investment.